Product information

Current status:

Cancelled Pre Market

Current status date:

2021-06-28

Original market date: ^{See footnote 1}

2001-04-05

Product name:

HYDROXYZINE HYDROCHLORIDE INJECTION

DIN:

02242864 Electronic product monograph is not available

Company:

FRESENIUS KABI CANADA LTD
165 Galaxy Blvd, Suite 100
Toronto
Ontario
Canada M9W 0C8

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intramuscular

Number of active ingredient(s):

1

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

28:24.92 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

N05BB01 HYDROXYZINE

Active ingredient group (AIG) number:^{See footnote5}

0106172004